Schonfeld Strategic Advisors LLC
Position in LXRX — Lexicon Pharmaceuticals, Inc.
CIK 1665241
NEW YORK, NY
Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$118,644
+$1,473 QoQ
Shares Held
49,435
-34.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 149 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. LXRX ranks #112 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in LXRX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,644 | 49,435 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $117,171 | 75,110 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,074 | 13,108 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,114,604 | 825,633 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,347,344 | 4,576,152 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,777,976 | 8,212,993 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,593,379 | 7,558,621 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,955,682 | 1,882,600 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $960,106 | 571,492 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,304,360 | 960,150 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $511,935 | 469,666 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,129,295 | 493,142 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $386,370 | 159,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $223,470 | 117,000 | Shares | Sole | 2023-02-14 | |
| 2020-12-31 | $258,894 | 75,700 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||